会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 21. 发明授权
    • Enzyme-mediated modification of fibrin for tissue engineering
    • 酶介导的组织工程纤维蛋白修饰
    • US06331422B1
    • 2001-12-18
    • US09057052
    • 1998-04-08
    • Jeffrey A. HubbellJason Schense
    • Jeffrey A. HubbellJason Schense
    • C12N910
    • A61L31/046A61F2310/00377A61L24/106A61L27/225A61L27/227C07K2319/00C12N5/0068C12N2533/56
    • The invention provides fibrin-based, biocompatible materials useful in promoting cell growth, wound healing, and tissue regeneration. These materials are provided as part of several cell and tissue scaffolding structures that provide particular application for use in wound-healing and tissue regenerating. Methods for preparing these compositions and using them are also disclosed as part of the invention. A variety of peptides may be used in conjunction with the practice of the invention, in particular, the peptide IKVAV, and variants thereof. Generally, the compositions may be described as comprising a protein network (e.g., fibrin) and a peptide having an amino acid sequence that comprises a transglutaminase substrate domain (e.g., a factor XIIIa substrate domain) and a bioactive factor (e.g., a peptide or protein, such as a polypeptide growth factor), the peptide being covalently bound to the protein network. Other applications of the technology include their use on implantable devices (e.g., vascular graphs), tissue and cell scaffolding. Other applications include use in surgical adhesive or sealant, as well as in peripheral nerve regeneration and angiogenesis.
    • 本发明提供了用于促进细胞生长,伤口愈合和组织再生的基于纤维蛋白的生物相容性材料。 提供这些材料作为几种细胞和组织脚手架结构的一部分,其提供用于伤口愈合和组织再生的特定应用。 制备这些组合物并使用它们的方法也作为本发明的一部分公开。 多种肽可以与本发明的实践结合使用,特别是肽IKVAV及其变体。 通常,组合物可以被描述为包括蛋白质网络(例如,纤维蛋白)和具有包含转谷氨酰胺酶底物结构域(例如,因子XIIIa底物结构域)和生物活性因子(例如肽或其衍生物)的氨基酸序列的肽 蛋白质,例如多肽生长因子),肽共价结合蛋白质网络。 该技术的其他应用包括它们在可植入装置(例如血管图),组织和细胞支架上的使用。 其他应用包括用于手术粘合剂或密封剂,以及在周围神经再生和血管生成中。
    • 27. 发明授权
    • Surfaces having desirable cell adhesive effects
    • 表面具有理想的细胞粘合效果
    • US5330911A
    • 1994-07-19
    • US527198
    • 1990-05-21
    • Jeffrey A. HubbellStephen P. MassiaNeil P. Desai
    • Jeffrey A. HubbellStephen P. MassiaNeil P. Desai
    • A61L27/00A61L17/14A61L27/22A61L27/34A61L29/04A61L29/08A61L31/04A61L31/10C07K17/08C07K17/14C12M3/00C12N5/00C12N5/06C12N11/08C07K5/10C07K7/06
    • C12N5/0068A61L17/145A61L27/227A61L27/34A61L29/048A61L29/085A61L31/047A61L31/10C07K17/08C12N2533/50
    • An absorbed protein-independent cell-adhesive surface is disclosed. The treated surface comprises a chemically derivatized material to which small peptides, having less than 12 amino acid residues and including YIGSR, RGD or REDV amino acid sequence are covalently linked to. The peptides of the present invention include a terminal glycine amino acid. Tresyl chloride activation of surface hydroxyl moieties provides the active surface sites by which a terminal glycine arm of a selected peptide attaches to form covalent bonds between the substrate and peptide. Peptides high with cell adhesive properties are bound in high efficiency.By way of example, surfaces which may be used in conjunction with the present invention include polymer, metal, and ceramic surfaces. The most preferred polymer surfaces include PHEMA and PET polymer surfaces, with the most preferred glass surfaces being glycophase glass.The present methods also include a pretreatment method which provides hydroxyl moieties to surfaces devoid of readily available hydroxyl moieties. The pretreatment, by way of example, comprises immersion of the surface in a mixture of formaldehyde and acetic acid.Methods of preparing the treated surfaces are also included in the present invention.Also included are surface-treated biomedical implant devices and cell culturing devices. The treated surface promotes an enhanced rate and an enhanced amount of cell adhesion to the surface, independent of media serum concentrations or other absorbed proteins. The treated surfaces of the present invention are thermally stable, reusable, peptide efficient (attached to surface only) and resistant to cell proteolysis.The invention further concerns polymeric substrates with a surface having physically interpenetrating water-soluble polymer chains, and methods for production thereof.
    • 公开了一种吸收的与蛋白质无关的细胞粘合剂表面。 经处理的表面包括化学衍生​​的材料,具有小于12个氨基酸残基并且包括YIGSR,RGD或REDV氨基酸序列的小肽共价连接到该材料上。 本发明的肽包括末端甘氨酸氨基酸。 表面羟基部分的甲苯氯化物活化提供活性表面位点,通过该活性表面位点所选肽的末端甘氨酸臂附着形成底物和肽之间的共价键。 具有细胞粘附性能的高肽结合效率高。 作为示例,可以与本发明结合使用的表面包括聚合物,金属和陶瓷表面。 最优选的聚合物表面包括PHEMA和PET聚合物表面,最优选的玻璃表面是糖相玻璃。 本方法还包括将羟基部分提供到没有容易得到的羟基部分的表面的预处理方法。 例如,预处理包括将表面浸入甲醛和乙酸的混合物中。 制备处理过的表面的方法也包括在本发明中。 还包括表面处理的生物医学植入装置和细胞培养装置。 经处理的表面促进了与培养基血清浓度或其他吸收的蛋白质无关的增强的速率和增加的表面附着量。 本发明的处理表面是热稳定的,可重复使用的,肽效率的(仅附着于表面)并且抗细胞蛋白水解。 本发明还涉及具有物理上互穿的水溶性聚合物链的表面的聚合物基材及其生产方法。